维普中文期刊产品整合服务
70篇 您的检索式:作者名="Herman JC"
    题名 作者 年代 出处 被引量
1The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in patients with dyslipidemia显示文摘Fruchart JC Sacks F Hermans MP American Journal of Cardiology0,,:2
2Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter 显示文摘Brandes JC Carraway H Herman JG 2007Oncogene2007,26,42:1
3The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
4The residual risk reduction initiative:a call to action to reduce residual vascular risk in patients with dyslip idemia显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,1:1
5The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in patients with dyslipipidemin显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
6The residual risk reduction initiative:A call to action to reduce residual vascular risk in dyslipidaemic patients显示文摘Fruchart JC Sacks FM Hermans MP 2008Diab Vasc Dis Res2008,5,4:1
7Indinavir calculi:diagnosis with magnetic resonance urography显示文摘 MATERNE R MAROT JC 2000Eur Urol2000,37,5:1
8Precipitation Kinetics of Microalloying Additions during Hot - rolling of HSLA Steels显示文摘Herman JC Donna YB Leruy V 1992ISIJ Int1992,32,6:1
9Optimal primer design u- sing the novel primer design program : MSPprimer provides accurate methylation analysis of the ATM promoter 显示文摘Brandes JC Carraway H Herman JG 2007Oneogene2007,26,42:1
10Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial eareino ma显示文摘BRIEN JC SHARIAT SF HERMAN MP 2010J Urol2010,184,:1
11Correct homeostasis model assessment (HOMA) evaluation uses the computer program显示文摘Levy JC Matthews DR Hermans MP 1998Diabetes Care1998,21,:1
12The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in dyslipidaemic patient显示文摘Fruchart JC Sacks FM Hermans MP 2008Diab Vasc Dis Res2008,5,4:1
13The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in patients with dyslipidemia 显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
14The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
15Correct homeostasis model assessment (HOMA) evaluation uses the computer program 显示文摘Levy JC Matthews DR Hermans MP 1998Diabetes Care1998,21,12:1
16Correct homeostasis model assessment(HOMA) evaluation uses computer program显示文摘Levv JC Matthews DR Hermans MP 1998Diabetes Care1998,21,12:1
17Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies显示文摘Katze nellenbogen RA Baylin SB Herman JC 1999Blood1999,93,12:1
18The residualrisk reduction initiative : a call to action to reduce residualvascular risk in dyslipidaemic patient显示文摘Fruchart JC Sacks FM Hermans MP 2008D/aZ> Vase Dis2008,5,4:1
19Correct homeostasis model assessment (HOMA)evaluation uses the computer program显示文摘Levy JC Matthews DR Hermans MP 1998Diabetes Care1998,21,12:1
20The residual risk reduction initiative:a call to action to reduce residual vascular riskin dyslipidaemic patient显示文摘Fruchart JC Sacks FM Hermans MP 2008Diab Vasc Dis Res2008,5,31:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费